Insiders · Profile

Smith Karen L.

Director at Aurinia Pharmaceuticals · Global Head of R&D and CMO at Jazz Pharmaceuticals. Filing since 13 Jun 2016. CIK 0001639637

Company
Date
Role
Action
Shares
Amount
Of holding
11 Nov 2024
Director
Sold at will
5,241
$44.18K
29.3%
12 Aug 2016
Global Head of R&D and CMO
Bought
608
$83.36K
4.5%
13 Jul 2016
Global Head of R&D and CMO
Bought
580
$83.30K
4.5%
13 Jun 2016
Global Head of R&D and CMO
Bought
557
$83.34K
4.5%
4 decisions on file.